John Aballi - 16 Oct 2026 Form 4 Insider Report for EXAGEN INC. (XGN)

Reporting relationship: President and CEO, Director
Issuer ticker: XGN
Reported as of: 16 Oct 2026
Net transaction value: -$269,791
SEC form: 4
Accepted by SEC: 19 Oct 2026, 16:52:31 UTC
Prior SEC filing: 16 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Jeffrey G. Black, as attorney-in-fact

Filing notes and source

Key filing fact

John Aballi filed Form 4 for EXAGEN INC. (XGN) on 19 Oct 2026.

Key facts

This page summarizes John Aballi's Form 4 filing for EXAGEN INC. (XGN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 Oct 2026, 16:52.

Change

Previous filing in this sequence was filed on 16 Mar 2026.
Current net transaction value: -$269,791.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001843113 Primary reporting owner

ABALLI JOHN

Relationship: President and CEO, Director
Address: C/O EXAGEN INC., 1261 LIBERTY WAY, VISTA
Signature: /s/ Jeffrey G. Black, as attorney-in-fact
Signature date: 19 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XGN transaction

Common Stock

Sale

Transaction value: -$269,791
Shares: -34,294
Change %: -4.1%
Price: $7.87
Shares after: 805,540
Date: 16 Oct 2026
Ownership: Direct
Footnotes: F1

XGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 40,401
Date: 16 Oct 2026
Ownership: by Spouse

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The sale is mandated by the Issuer's satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.